In the latest episode of The Line Podcast, recorded between November 5th and 6th, 2026, Matt Gurney and Jen Gerson are joined by special guest Stephanie Levitz of The Globe and Mail.
This episode is also brought to you by Cameco. Building Canada’s energy future means creating jobs for Canadian workers. That’s why the AP1000 reactor is the right choice for Canada: it is already operating and ready to deliver the power we need. Choosing the AP1000 means a reactor built by Canadians, creating skilled jobs in construction, fabrication and the trades while keeping more investment and economic benefits here at home. If we are serious about creating Canadian jobs and strengthening our economy, the choice is clear. To learn more,
[visit][ap1000.cameco.com].
First up, a brief explainer: due to Jen being at a conference, part of this episode was recorded earlier in the week, after the midterms, but before the Canadian federal budget had been released. To avoid ignoring one of the huge stories of the week, Matt recorded a special segment of the podcast on Friday, after Jen had left for her event. In that segment, Stephanie Levitz joins Matt for a quick discussion of the federal budget. What’s in it, what’s missing, and what does it tell us about the Carney government’s priorities? They take stock of what Ottawa is promising, what it’s actually prepared to spend money on, and what Canadians should take away from it all.
This episode is also brought to you by BioCanRx. We’ve been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This month we’re addressing common questions, like: are immunotherapy technologies dual-use?While many immunotherapies are personalized using a patient’s own cells, the research and manufacturing infrastructure behind them can produce other important products, like vaccines. The people behind those research, manufacturing, and clinical delivery processes are also extremely capable and versatile. Greater support for translational research and clinical trials would help grow this workforce and build capabilities that extend well beyond cancer. In a health emergency, that capacity could also help Canada respond quickly to urgent needs for new treatments and vaccines .Thanks to BioCanRx for continuing to partner with
The Lineto share this information. Visit[BioCanRx.com]to learn more.
And then, as recorded earlier in the week, Matt and Jen have a lengthy discussion about the U.S. midterm elections and what they mean for Canada. They consider the political forces shaping the results, what the elections tell us about Donald Trump’s America, and what Canadians should expect from Washington in the years ahead. Whatever happens in American domestic politics, Canada still has to figure out how to deal with a neighbour whose political priorities and relationship with the rest of the world have changed dramatically.
Finally, your hosts pivot from the American midterms to how they’re being received here in Canada. Jen breaks her own rule about not talking about the Conservatives and talks about the Conservatives. Matt, meanwhile, has a warning for some Canadian conservatives: he thinks they’re having a hard time coming to grips with the fact that they’re Liberals now. And the sooner they figure that out, the better.
All that and more in the latest episode of The Line Podcast.
YouTube:
Video goes live at 6 p.m Eastern/4 Mountain.
Spotify:
Apple:
Please sign up at those options not just for this episode, or future episodes of The Line Podcast, but so that you can also receive our other podcast series, On the Line, which releases new episodes every Tuesday morning. In case you missed it, here is last Tuesday’s episode, where Jen Gerson speaks with Jeff Collins, director of the Palmer Institute for Canadian Leadership in Charlottetown, P.E.I., about Canada’s military procurement problems, the country’s evolving national security strategy, and whether our newfound enthusiasm for getting our elbows up against the Americans makes any sense when it comes to national defence.
That’s all for now! Talk to you guys soon.
The Line is entirely reader and advertiser funded. No federal subsidies, no bailouts. If you value our work, please consider supporting us by subscribing or making a donation. Donations are not subscriptions and do not unlock paywalled content, but they help keep The Line independent
To contact The Line with a general inquiry or comment, please email info@readtheline.ca. For other ways to connect with us or to follow us on social media, please see our LinkTree.
